The antigen-binding fragment of human gamma immunoglobulin prevents amyloid β-peptide folding into β-sheet to form oligomers
PDF | HTML | How to cite
Metrics: PDF 1743 views | HTML 5209 views | ?
Victòria Valls-Comamala1, Biuse Guivernau1, Jaume Bonet2, Marta Puig1, Alex Perálvarez-Marín3, Ernest Palomer1, Xavier Fernàndez-Busquets4,5, Xavier Altafaj6, Marta Tajes7, Albert Puig-Pijoan8, Rubén Vicente1, Baldomero Oliva2 and Francisco J. Muñoz1
1Laboratory of Molecular Physiology, Faculty of Health and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain
2Laboratory of Structural Bioinformatics (GRIB), Faculty of Health and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain
3Unitat de Biofísica, Departament de Bioquímica i de Biologia Molecular, Facultat de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain
4Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain
5ISGlobal, Barcelona Centre for International Health Research, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain
6Bellvitge Biomedical Research Institute (IDIBELL) - Unit of Neuropharmacology and Pain, University of Barcelona, Barcelona, Spain
7Heart Diseases Biomedical Research Group, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain
8Servei de Neurologia, Hospital del Mar-IMIM-Parc de Salut Mar, Barcelona, Spain
Francisco J. Muñoz, email: [email protected]
Keywords: Alzheimer’s disease, amyloid, immunoglobulin, Fab, oligomers
Received: December 22, 2016 Accepted: March 22, 2017 Published: April 13, 2017
The amyloid beta-peptide (Aβ) plays a leading role in Alzheimer’s disease (AD) physiopathology. Even though monomeric forms of Aβ are harmless to cells, Aβ can aggregate into β-sheet oligomers and fibrils, which are both neurotoxic. Therefore, one of the main therapeutic approaches to cure or delay AD onset and progression is targeting Aβ aggregation. In the present study, we show that a pool of human gamma immunoglobulins (IgG) protected cortical neurons from the challenge with Aβ oligomers, as assayed by MTT reduction, caspase-3 activation and cytoskeleton integrity. In addition, we report the inhibitory effect of IgG on Aβ aggregation, as shown by Thioflavin T assay, size exclusion chromatography and atomic force microscopy. Similar results were obtained with Palivizumab, a human anti-sincitial virus antibody. In order to dissect the important domains, we cleaved the pool of human IgG with papain to obtain Fab and Fc fragments. Using these cleaved fragments, we functionally identified Fab as the immunoglobulin fragment inhibiting Aβ aggregation, a result that was further confirmed by an in silico structural model. Interestingly, bioinformatic tools show a highly conserved structure able to bind amyloid in the Fab region. Overall, our data strongly support the inhibitory effect of human IgG on Aβ aggregation and its neuroprotective role.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.